RxDoctor Payments Data

James Meiling, DO

Physical Medicine & Rehabilitation · Rochester, MNNPI 1669933347

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Biogen at 35.6% of the total.

$717in general payments, 2019–2025

Across 12 payments — averaging $59.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$256
  • Checkpoint Surgical, Inc$123
  • NS Pharma, Inc.$104
  • Medtronic$90
  • Saol Therapeutics Inc.$44
  • Merz North America, Inc.$41
  • plus $60 from 2 others

What the payments were for

  • Food & beverage$717100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen4$256
Checkpoint Surgical, Inc1$123
NS Pharma, Inc.1$104
Medtronic1$90
Saol Therapeutics Inc.1$44
Merz North America, Inc.1$41
Cadwell Industries, Inc2$38
AstraZeneca1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$717 in reported general payments places this provider in the 85th percentile of 196 physical medicine & rehabilitation providers in Minnesota.

See all physical medicine & rehabilitation providers in Minnesota

Medicare billing

Part B allowed, 2024
$25,800
Medicare patients
131
Services billed
299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mycophenolate Mofetil12$750
Gabapentin25$207

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →